Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Study reveals why pigs don’t get sick from COVID-19
Pig cells undergo apoptosis - or controlled cell death - in response to infection with COVID-19.
Findings could lead to new treatments for human patients.

A new study shedding light on why pigs don’t get sick with COVID-19 could lead to better treatments in humans, according to new research.

Since the beginning of the pandemic, research into pigs has revealed that the animals do not display clinical signs of the disease, nor do they transmit the virus to other animals.

To find out why this was happening, researchers at IOWA State University introduced the virus to cultured porcine and human respiratory epithelial cells that line the respiratory tract. 

They found the pig cells underwent apoptosis - or controlled cell death - in response to infection at a higher rate than human epithelial cells. The findings are published in the journal Cell Death Discovery.

Study author Rahul Nelli, a research assistant professor of veterinary diagnostic and production animal medicine, said: “When we looked under the microscope, there was an interesting phenomenon going on inside the cells. The nuclei of the infected pig cells were starting to shred into fragments but not uninfected pig cells.” 

Shredding of the nucleus is a sign of apoptosis, which could be significant in helping pigs to avoid symptoms after exposure to SARS-CoV-2. If triggered early in the infection, apoptosis causes very little tissue damage and confines viral infection, thereby mitigating the risk of severe illness.

While human cells can also undergo apoptosis in response to coronavirus infection, the researchers found they do so much less often than pig cells. According to the study, porcine cells are around 100 times more likely to undergo apoptosis than human cells.

Human cells are more prone to succumb to necrosis, a less regulated form of cell death than apoptosis. The contents of a cell escape into the surrounding space during necrosis, triggering a strong hyperimmune response not seen during apoptosis. 

The study concludes that a wide-scale apoptosis response helps avoid disease because it disposes of infected cells quickly without the immune system overreacting. Conversely, wide-scale necrosis and the resulting hyperimmune response is less favourable to host cells. 

Co-author Luis Gimenez-Lirola, an associate professor of veterinary diagnostic and production animal medicine, commented: “We don’t want to over-conclude, but this response is probably something intrinsic to the pig immune system that is innate and not acquired. The idea is to kill the virus subtly but fast enough, so there’s not an excessive immune response triggered.” 

The team hopes that further study could pave the way to therapies to trigger apoptosis in human cells, helping those infected with COVID- to avoid severe symptoms.

Become a member or log in to add this story to your CPD history

FIVP launches CMA remedies survey

News Story 1
 FIVP has shared a survey, inviting those working in independent practice to share their views on the CMA's proposed remedies.

The Impact Assessment will help inform the group's response to the CMA, as it prepares to submit further evidence to the Inquiry Group. FIVP will also be attending a hearing in November.

Data will be anonymised and used solely for FIVP's response to the CMA. The survey will close on Friday, 31 October 2025. 

Click here for more...
News Shorts
CMA to host webinar exploring provisional decisions

The Competition and Markets Authority (CMA) is to host a webinar for veterinary professionals to explain the details of its provisional decisions, released on 15 October 2025.

The webinar will take place on Wednesday, 29 October 2025 from 1.00pm to 2.00pm.

Officials will discuss the changes which those in practice may need to make if the provisional remedies go ahead. They will also share what happens next with the investigation.

The CMA will be answering questions from the main parties of the investigation, as well as other questions submitted ahead of the webinar.

Attendees can register here before Wednesday, 29 October at 11am. Questions must be submitted before 10am on 27 October.

A recording of the webinar will be accessible after the event.